A detailed history of Victory Capital Management Inc transactions in Geron Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 70,033 shares of GERN stock, worth $244,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,033
Previous 138,555 49.45%
Holding current value
$244,415
Previous $587,000 46.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$4.17 - $4.99 $285,736 - $341,924
-68,522 Reduced 49.45%
70,033 $317,000
Q2 2024

Aug 05, 2024

BUY
$3.1 - $5.09 $246,825 - $405,270
79,621 Added 135.1%
138,555 $587,000
Q1 2024

May 03, 2024

SELL
$1.75 - $3.44 $5,206 - $10,234
-2,975 Reduced 4.81%
58,934 $194,000
Q4 2023

Feb 05, 2024

BUY
$1.74 - $2.31 $23,657 - $31,406
13,596 Added 28.14%
61,909 $130,000
Q3 2023

Nov 06, 2023

BUY
$2.11 - $3.28 $2,031 - $3,158
963 Added 2.03%
48,313 $102,000
Q2 2023

Jul 27, 2023

BUY
$1.97 - $3.69 $10,303 - $19,298
5,230 Added 12.42%
47,350 $151,000
Q1 2023

May 02, 2023

BUY
$2.14 - $3.4 $9,386 - $14,912
4,386 Added 11.62%
42,120 $91,000
Q4 2022

Feb 10, 2023

BUY
$2.03 - $2.42 $690 - $822
340 Added 0.91%
37,734 $91,000
Q4 2022

Feb 09, 2023

SELL
$2.03 - $2.42 $246,994 - $294,446
-121,672 Reduced 76.49%
37,394 $90,000
Q3 2022

Nov 02, 2022

BUY
$1.67 - $2.94 $182,405 - $321,121
109,225 Added 219.15%
159,066 $372,000
Q2 2022

Aug 01, 2022

SELL
$1.19 - $1.65 $341 - $473
-287 Reduced 0.57%
49,841 $77,000
Q1 2022

May 04, 2022

BUY
$0.99 - $1.6 $6,507 - $10,516
6,573 Added 15.09%
50,128 $71,000
Q4 2021

Feb 07, 2022

SELL
$1.22 - $1.72 $1,423 - $2,007
-1,167 Reduced 2.61%
43,555 $53,000
Q3 2021

Nov 02, 2021

SELL
$1.2 - $1.5 $1,752 - $2,190
-1,460 Reduced 3.16%
44,722 $61,000
Q2 2021

Aug 03, 2021

SELL
$1.25 - $1.83 $910 - $1,332
-728 Reduced 1.55%
46,182 $65,000
Q1 2021

May 04, 2021

SELL
$1.52 - $2.1 $2,220 - $3,068
-1,461 Reduced 3.02%
46,910 $74,000
Q4 2020

Feb 01, 2021

BUY
$1.55 - $2.05 $3,062 - $4,050
1,976 Added 4.26%
48,371 $77,000
Q3 2020

Nov 09, 2020

BUY
$1.59 - $2.19 $2,410 - $3,320
1,516 Added 3.38%
46,395 $81,000
Q2 2020

Aug 07, 2020

BUY
$1.05 - $2.18 $16,237 - $33,711
15,464 Added 52.57%
44,879 $98,000
Q1 2020

May 04, 2020

SELL
$0.89 - $1.49 $593 - $993
-667 Reduced 2.22%
29,415 $35,000
Q4 2019

Feb 04, 2020

BUY
$1.27 - $1.54 $2,376 - $2,881
1,871 Added 6.63%
30,082 $39,000
Q3 2019

Nov 12, 2019

BUY
$1.15 - $1.59 $32,442 - $44,855
28,211 New
28,211 $38,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.32B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.